Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Prevention of early-onset invasive neonatal group B streptococcal disease in a private hospital setting: the superiority of culture-based protocols

Article Abstract:

Swabbing a pregnant woman's vagina and rectum and then culturing the fluid to see if it grows group B streptococci is an effective way to stop the transmission of the bacteria to the baby. Only women who test positive would be given antibiotics, and this completely prevented transmission in 9,304 deliveries.

Author: Main, Elliott K., Slagle, Teri
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2000
Cultures (Biology)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention or early-onset neonatal group B streptococcal disease

Article Abstract:

Giving antibiotics to pregnant women who have risk factors for group B streptococcal infection can prevent the infection in over 80%, according to a study of 316 women. It is best to give the antibiotics at least two hours before delivery for greatest effectiveness.

Author: Rhoads, George G., Clark, Penny, Lin, Feng Ying C., Brenner, Ruth A., Johnson, Yvette R., Azimi, Parvin H., Philips, Joseph B., III, Regan, Joan A., Weisman, Leonard E., King, Fanhui, Clemens, John D.
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2001
Usage, Antibiotics

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Rapid intrapartum detection of group B streptococcal colonization with an enzyme immunoassay

Article Abstract:

Use of the ICON Strep B rapid immunoenzyme assay does not appear suitable for general screening of group B streptococcal infection. Severe group B streptococcal infections affect up to 15,000 newborn infants annually, most of which are acquired from the mother during delivery. The death rate from these infections is as high as 50% among premature infants. The new ICON Strep B immunoassay and the standard broth culture test were used to detect group B streptococcal colonization in vaginal samples taken from 424 pregnant women. Of 98 confirmed positive cultures, 90 showed light colonization. The Icon assay was positive in all eight women with heavy group B streptococcal colonization but was positive in only one of the 90 patients with light colonization. Of 79 of the infants born to women with light colonization, 19 were diagnosed with suspected streptococcal infection and three had severe infection.

Author: Clark, Penny, Duff, Patrick, Armer, Traci, Saravanos, Karen
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1993
Methods, Evaluation, Product/Service Evaluation, Diagnosis, Medical screening, Health screening, Enzyme-linked immunosorbent assay, ICON Strep B (Medical test kit)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Care and treatment, Streptococcal infections, Prevention, Pregnant women
Similar abstracts:
  • Abstracts: Incidence of intrapartum maternal risk factors for identifying neonates at risk for early-onset group B streptococcal sepsis: a prospective study
  • Abstracts: Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States
  • Abstracts: Presence of mutation conferring resistance to lamivudine in plasma and cerebrospinal fluid of HIV-1 infected patients
  • Abstracts: A randomized, double-blind, placebo-controlled comparison of the effect of nitrofurantoin monohydrate macrocrystals on the development of urinary
  • Abstracts: Marked variation in responses to long-term nitric oxide inhibition during pregnancy in outbred rats from two different colonies
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.